Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Angle Plc (AGLE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
14.80 +0.80    +5.71%
10:00:17 - Real-time Data. Currency in GBP ( Disclaimer )
  • Volume: 858,963
  • Bid/Ask: 14.50 / 15.50
  • Day's Range: 13.87 - 15.38
Type:  Equity
Market:  United Kingdom
ISIN:  GB0034330679 
SEDOL:  3433067
Angle 14.80 +0.80 +5.71%

AGLE Ratios

 
Use this page to view Angle key financial ratios such as their Price-to-Earnings (P/E Ratio), Earnings-Per-Share (EPS), Return-On-Investment (ROI) and others based on the latest AGLE financial reports.
InvestingPro Advanced Ratios
Name Company Industry
   
P/E Ratio TTM -1.81 26.28
Price to Sales TTM 22.18 2.95
Price to Cash Flow MRQ -7.78 29.27
Price to Free Cash Flow TTM -2.5 44.86
Price to Book MRQ 1.26 3.35
Price to Tangible Book MRQ 1.29 -12.64
   
Profitability: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Gross margin TTM 17.55% 58.15
Gross Margin 5YA -1.63% 59.49
Operating margin TTM -1,373.27% 5.72
Operating margin 5YA -1,646.4% 6.69
Pretax margin TTM -1,350.22% 4.54
Pretax margin 5YA -1,718.28% 4.93
Net Profit margin TTM -1,225.41% 2.26
Net Profit margin 5YA -1,482.35% 2.81
   
Revenue/Share TTM 0.01 35.7
Basic EPS ANN -0.09 7.48
Diluted EPS ANN -0.09 7.47
Book Value/Share MRQ 0.12 32.31
Tangible Book Value/Share MRQ 0.11 -19.93
Cash/Share MRQ 0.09 4.11
Cash Flow/Share TTM -0.06 10.13
   
Management Effectiveness: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Return on Equity TTM -69.68% 8.7
Return on Equity 5YA -46.87% 24.71
Return on Assets TTM -54.36% 3.38
Return on Assets 5YA -39.7% 10.62
Return on Investment TTM -58.22% 5.95
Return on Investment 5YA -47.43% 16.18
   
EPS(MRQ) vs Qtr. 1 Yr. Ago MRQ 3.97% -128.25
EPS(TTM) vs TTM 1 Yr. Ago TTM -21.93% -23.21
5 Year EPS Growth 5YA 0% 5.29
Sales (MRQ) vs Qtr. 1 Yr. Ago MRQ 185.44% 6.35
Sales (TTM) vs TTM 1 Yr. Ago TTM 60.04% 4.31
5 Year Sales Growth 5YA 15.89% 9.71
5 Year Capital Spending Growth 5YA 89.66% 9.25
   
Quick Ratio MRQ 6 0.66
Current Ratio MRQ 7.51 0.88
LT Debt to Equity MRQ - 33.8
Total Debt to Equity MRQ 14.26% 44.96
Efficiency    
Asset Turnover TTM 0.04 0.43
Inventory Turnover TTM 0.75 2.13
Revenue/Employee TTM 10.51K 438.62K
Net Income/Employee TTM -128.77K -71.21K
Receivable Turnover TTM 1.67 4.57
   
Dividend Yield ANN - 1.77
Dividend Yield 5 Year Avg. 5YA - 1.54
Dividend Growth Rate ANN 0% 0.05
Payout Ratio TTM - 39.78
TTM = Trailing Twelve Months  5YA = 5-Year Average  MRQ = Most Recent Quarter
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced valuation and financial ratios for in-depth analysis of company financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AGLE Price Commentary

Write your thoughts about Angle Plc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Theo Marshall
Theo Marshall May 25, 2023 8:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Still buying after today's announcement.
Theo Marshall
Theo Marshall May 18, 2023 8:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Too cheap
virg smit
virg smit Jan 31, 2022 17:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1643649862_23581.jpg
Whilst there is no news the share price will drift off to the £1.00 region-its worth considering adding to holdings if the price sinks somewhat further towards the 80+region.
virg smit
virg smit Oct 15, 2021 11:21
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The prognosis for this share price is unbeleivable as the CEO is aiming to dominate the world with blood tests that find and deliver live cancer cells-so no more biopsies !The assumption is the USA FDA approve their M/C application which is expected towards the end of the year.Some ridiculous projections for the sp suggest circa £1500 yes thats one thousand five hundred pounds a share-because their is no competition -suggest check out the website for the full details of patients, posters and peer reviews.Of course the immediate share price will collapse and recover if no FDA approval-nevertheless a holding of a couple of thousand shares will give £3million in a very short time IF APPROVED.Many years of trading and I have never seen anything like this.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email